Minimally Invasive Surgery for Stomach Cancer

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Recruiting Observational Study
Gastrostomy Gastric GastroEsophageal Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for adults with early-stage gastric cancer to compare two types of surgery. Participants will undergo either a minimally invasive proximal gastrectomy or a total gastrectomy.

Are You a Good Fit for This Trial?

You may be able to join if

  • I can speak and read English, Spanish, Japanese, or Korean.
  • I have been diagnosed with non-metastatic gastric or gastroesophageal junction cancer confirmed by a biopsy.
  • I am scheduled for surgery with the aim to cure my cancer.
  • I am at least 18 years old.

You may not be able to join if

  • I have a malabsorption syndrome.
  • I have narcotic dependence with an average daily dose greater than 5 mg of oral morphine equivalent.
  • I am unable to comply with the study procedures or follow-up, as determined by the researchers.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion: 1. Able to speak and read English, Spanish, Japanese or Korean 2. Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention 3. Age ≥ 18 Exclusion: 1. Participants with known malabsorp…
Contacts

Naruhiko Ikoma, MD

(832) 729-2675

nikoma@mdanderson.org

CONTACT